1. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Issue 4 (November 2018) Authors: Sfanos, Karen; Markowski, Mark; Peiffer, Lauren; Ernst, Sarah; White, James; Pienta, Kenneth; Antonarakis, Emmanuel; Ross, Ashley Journal: Prostate cancer and prostatic diseases Issue: Volume 21:Issue 4(2018) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cutaneous finger and tongue metastases in renal cell carcinoma. Issue 6 (21st June 2019) Authors: Abro, Calvin; Sedhom, Ramy; Soni, Abha; Markowski, Mark Journal: BMJ case reports Issue: Volume 12:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies. Issue 3 (18th September 2021) Authors: Marshall, Catherine Handy; Chen, Yongmei; Kuo, Claire; Cullen, Jennifer; Jiang, Jiji; Rosner, Inger; Markowski, Mark; McLeod, David G.; Trock, Bruce J.; Eisenberger, Mario A. Journal: Journal of urology Issue: Volume 206:Issue 3(2021) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MP27-15 SABIZABULIN HAS BOTH CYTOTOXIC AND CYTOSTATIC ACTIVITY IN PHASE 1B/2 CLINICAL OF MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER WHO PROGRESSED ON ANDROGEN RECEPTOR TARGETING AGENTS. (May 2022) Authors: Markowski, Mark; Eisenberger, Mario; Pieczonka, Christopher; Getzenberg, Robert; Rodriguez, Domingo; Barnette, K. Gary; Steiner, MItchell; Saltzstein, Daniel; Antonarakis, Emmanuel; Tutrone, Ronald Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial. Issue 6 (20th February 2023) Authors: Tran, Phuoc T.; Lowe, Kathryn; Tsai, Hua-Ling; Song, Daniel Y.; Hung, Arthur Y.; Hearn, Jason W.D.; Miller, Steven; Proudfoot, James A.; Deek, Matthew P.; Phillips, Ryan; Lotan, Tamara; Paller, Channing J.; Marshall, Catherine H.; Markowski, Mark; Dipasquale, Shirl; Denmeade, Samuel; Carducci, Mi... Journal: Journal of clinical oncology Issue: Volume 41:Issue 6(2023) Page Start: 1307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗